BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Do you lean your seat back on the plane? These travel pros — and real-life couple — won't do it. - 2RFK Jr. succeeds in changing hepatitis B recommendation | The Excerpt
- 3Step by step instructions to Pick the Right Dental specialist for Your Dental Inserts Technique
- 4Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
- 5New study measures titanium in Apollo rock to uncover Moon’s early chemistry
- Ancient Pompeii construction site reveals the process for creating Roman concrete
- Philippines evacuates 3,000 villagers after volcano activity raises alert level
- Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission.
- IDF destroys regime's missile, sea mine production site in Yazd amid nationwide airstrikes
- Step by step instructions to Explore Assessment Ramifications of Disc Rates
- 6 Fun Urban areas For Seniors To Travel
- Creative Style: 10 Architects Reclassifying the Business
- Figure out How to Plan for Your Web-based Degree monetarily
- Vote In favor of Your Favored IT Administration
